Literature DB >> 8971231

Methotrexate patient education: a quality improvement study.

M R Burma, J W Rachow, S Kolluri, K G Saag.   

Abstract

OBJECTIVE: To determine patients' knowledge of the safe use and toxicity of methotrexate (MTX) and to define educational interventions implemented by a rheumatology nurse that improved patients' understanding of MTX therapy.
METHODS: One hundred eighty-three patients from a university-based rheumatology clinic who were taking MTX completed an initial knowledge questionnaire concerning the proper use and possible toxicity of MTX. Following completion, a nurse reviewed the correct answers with each patient and provided written information on MTX. One hundred thirty-eight of these patients completed a followup questionnaire at the next visit or by mail. The questionnaires were analyzed, and a total MTX knowledge score was calculated.
RESULTS: MTX knowledge improved significantly between questionnaires; mean total score (+/- SD) increased from 7.32 +/- 3.99 to 10.23 +/- 3.29 (P < 0.001). After accounting for a person's initial questionnaire score, the addition of a supplemental "MTX pocket-card" was associated with a higher score on the follow-up questionnaire (adjusted odds ration [OR] = 2.37; 95% confidence interval [CI] 1.14, 4.95; P = 0.021). Patients over age 55 were 4 times more likely to have a poorer score compared with patients under age 45 (adjusted OR = 0.23; 95% CI 0.07, 0.73; P = 0.013).
CONCLUSION: Knowledge of the toxicity and safe use of MTX was significantly improved by a patient education program utilizing a rheumatology nurse. Older individuals appear to be at higher risk for knowledge deficits. A supplemental MTX pocket-card proved to be a simple but beneficial addition to our MTX educational program.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8971231     DOI: 10.1002/1529-0131(199606)9:3<216::aid-anr1790090310>3.0.co;2-5

Source DB:  PubMed          Journal:  Arthritis Care Res        ISSN: 0893-7524


  3 in total

1.  EULAR evidence-based recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases.

Authors:  J N Hoes; J W G Jacobs; M Boers; D Boumpas; F Buttgereit; N Caeyers; E H Choy; M Cutolo; J A P Da Silva; G Esselens; L Guillevin; I Hafstrom; J R Kirwan; J Rovensky; A Russell; K G Saag; B Svensson; R Westhovens; H Zeidler; J W J Bijlsma
Journal:  Ann Rheum Dis       Date:  2007-07-27       Impact factor: 19.103

2.  Improvement in medication education in a pediatric subspecialty practice.

Authors:  Aarat M Patel; Kathryn S Torok; Paul Rosen
Journal:  Pediatr Rheumatol Online J       Date:  2010-09-15       Impact factor: 3.054

3.  Poor knowledge of methotrexate associated with older age and limited English-language proficiency in a diverse rheumatoid arthritis cohort.

Authors:  Jennifer L Barton; Gabriela Schmajuk; Laura Trupin; Jonathan Graf; John Imboden; Edward H Yelin; Dean Schillinger
Journal:  Arthritis Res Ther       Date:  2013       Impact factor: 5.156

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.